Recent advances in hypertension in sub-Saharan Africa

Heart

Volumn 99, Issue 19, 2013, Pages 1390-1397

  Ogah, Okechukwu S ^a,b   Rayner, Brian L ^c  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b Nnamdi Azikiwe Secretariat   (Nigeria)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANTIHYPERTENSIVE AGENT; CYTOCHROME P450; CYTOCHROME P450 3A5; SODIUM CHANNEL;

ADULT; AFRICA SOUTH OF THE SAHARA; ALCOHOL CONSUMPTION; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CULTURAL FACTOR; DIETARY INTAKE; EPIDEMIC; ETHNICITY; FEMALE; FOOD INTAKE; GENE MUTATION; HIGH POTASSIUM INTAKE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INTERVENTION STUDY; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LIFESTYLE; MALE; MIGRATION; OBESITY; OUTCOME ASSESSMENT; PATHOGENESIS; PRACTICE GUIDELINE; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; RURAL POPULATION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM INTAKE; SODIUM RESTRICTION; STARVATION; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; URBAN AREA; URBANIZATION;

ADULT; AFRICA SOUTH OF THE SAHARA; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; PREVALENCE; RESIDENCE CHARACTERISTICS; RISK FACTORS; RURAL HEALTH; TRANSIENTS AND MIGRANTS; URBAN HEALTH;

EID: 84883771134     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-303227     Document Type: Article

References (60)

1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-60.
2. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23. (Pubitemid 40138015)
3. Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011;377:568-77.
4. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation 2005;112:3562-8. (Pubitemid 43739533)
5. Seedat YK. Hypertension in developing nations in sub-Saharan Africa. J Hum Hypertens 2000;14:739-47.
6. Mensah GA. Epidemiology of stroke and high blood pressure in Africa. Heart 2008;94:697-705. (Pubitemid 351752297)
7. WHO. WHO STEPS Instrument. 20 Avenue Appia, 1211 Geneva 27, Switzerland: World Health Organization 2013:The WHO STEPwise approach to chronic disease risk factor surveillance (STEPS).
8. Twagirumukiza M, De Bacquer D, Kips JG, et al. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens 2011;29:1243-52.
9. Rosenthal T, Grossman E, Knecht A, et al. Blood pressure in Ethiopian immigrants in Israel: comparison with resident Israelis. J Hypertens Suppl 1989;7:S53-5. (Pubitemid 19099048)
10. UNPP. UN Population division: Department of Economic and Social affairs. World Population Prospects: The 2008 Revision population database. 2006.
11. WHO. STEPS survey on Chronic Disease Risk Factors. WHO, Regional office for Africa, 2009.
12. Addo J, Smeeth L, Leon DA. Prevalence, detection, management, and control of hypertension in Ghanaian civil servants. Ethn Dis 2008;18:505-11.
13. Damasceno A, Azevedo A, Silva-Matos C, et al. Hypertension prevalence, awareness, treatment, and control in Mozambique: urban/rural gap during epidemiological transition. Hypertension 2009;54:77-83.
14. Oladapo OO, Salako L, Sodiq O, et al. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Cardiovasc J Afr 2010;21:26-31.
15. Ekwunife OI, Udeogaranya PO, Nwatu IL. Prevalence, awareness, treatment and control of hypertension in a Nigerian population. Health 2010;2:731-5.
16. Dzudie A, Kengne AP, Muna WF, et al. Prevalence, awareness, treatment and control of hypertension in a self-selected sub-Saharan African urban population: a cross-sectional study. BMJ Open 2012;2:e001217.
17. Damasceno A, Mayosi BM, Sani M, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med 2012;172:1386-94.
18. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112-23.
19. Hult M, Tornhammar P, Ueda P, et al. Hypertension, diabetes and overweight: looming legacies of the Biafran famine. PLoS ONE 2010;5:e13582.
20. Jones ES, Owen EP, Rayner BL. The Association of the R563Q Genotype of the ENaC with Phenotypic Variation in Southern Africa. Am J Hypertens 2012;25:1286-86.
21. Jones ES, Owen EP, Davidson JS, et al. The R563Q mutation of the epithelial sodium channel beta-subunit is associated with hypertension. Cardiovasc J Afr 2010;22:241-4.
22. Bochud M, Elston RC, Maillard M, et al. Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean). Kidney Int 2005;67:61-9. (Pubitemid 40019226)
23. Rayner B, Musekiwa A, Lombard C, et al. The A142V polymorphism of the G protein-coupled receptor kinase 4 gene predicts natriuretic response to saline challenge in young normotensive lean Black and White South African men. Nephrol Rev 2011;3:e9.
24. Bochud M, Eap CB, Elston RC, et al. Association of CYP3A5 genotypes with blood pressure and renal function in African families. J Hypertens 2006;24:923-9. (Pubitemid 43670464)
25. Barnighausen T, Welz T, Hosegood V, et al. Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population with very high HIV prevalence in South Africa. J Hum Hypertens 2008;22:236-9. (Pubitemid 351266498)
26. Malaza A, Mossong J, Barnighausen T, et al. Hypertension and obesity in adults living in a high HIV prevalence rural area in South Africa. PLoS ONE 2012;7:e47761.
27. Nel D, Rayner B. HIV vasculopathy of renal artery manifesting as severe hypertension in a young female: case report and review. Vasc Dis Manag 2011;8:E40-4.
28. Rose G, Stamler J. The INTERSALT study: background, methods and main results. INTERSALT Co-operative Research Group. J Hum Hypertens 1989;3:283-8. (Pubitemid 19247895)
29. Redelinghuys M, Norton GR, Scott L, et al. Relationship between urinary salt excretion and pulse pressure and central aortic hemodynamics independent of steady state pressure in the general population. Hypertension 2010;56:584-90.
30. Majane OH, Norton GR, Maseko MJ, et al. The association of waist circumference with ambulatory blood pressure is independent of alternative adiposity indices. J Hypertens 2007;25:1798-806. (Pubitemid 47356619)
31. Tiago AD, Samani NJ, Candy GP, et al. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation 2002;106:1483-7.
32. Norton GR, Maseko M, Libhaber E, et al. Is prehypertension an independent predictor of target organ changes in young-to-middle-aged persons of African descent? J Hypertens 2008;26:2279-87.
33. Libhaber CD, Norton GR, Majane OH, et al. Contribution of central and general adiposity to abnormal left ventricular diastolic function in a community sample with a high prevalence of obesity. Am J Cardiol 2009;104:1527-33.
34. Woodiwiss AJ, Libhaber CD, Majane OH, et al. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens 2008;21:1144-51.
35. Norton GR, Majane OH, Libhaber E, et al. The relationship between blood pressure and left ventricular mass index depends on an excess adiposity. J Hypertens 2009;27:1873-83.
36. Majane OH, Vengethasamy L, du Toit EF, et al. Dietary-induced obesity hastens the progression from concentric cardiac hypertrophy to pump dysfunction in spontaneously hypertensive rats. Hypertension 2009;54:1376-83.
37. Mayosi BM, Lawn JE, van Niekerk A, et al. Health in South Africa: changes and challenges since 2009. Lancet 2012;380:2029-43.
38. Peer N, Steyn K, Dennison CR, et al. Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: the Hi-Hi study. Am J Hypertens 2008;21:896-902.
39. Ekore RI, Ajayi IO, Arije A. Case finding for hypertension in young adult patients attending a missionary hospital in Nigeria. Afr Health Sci 2009;9:193-9.
40. Addo J, Smeeth L, Leon DA. Hypertensive target organ damage in Ghanaian civil servants with hypertension. PLoS ONE 2009;4:e6672.
41. Stewart S, Libhaber E, Carrington M, et al. The clinical consequences and challenges of hypertension in urban-dwelling black Africans: insights from the Heart of Soweto Study. Int J Cardiol 2009;146:22-7.
42. Oladapo OO, Salako L, Sadiq L, et al. Target-organ damage and cardiovascular complications in hypertensive Nigerian Yoruba adults: a cross-sectional study. Cardiovasc J Afr 2012;23:379-84.
43. Akintunde AA, Familoni OB, Akinwusi PO, et al. Relationship between left ventricular geometric pattern and systolic and diastolic function in treated Nigerian hypertensives. Cardiovasc J Afr 2010;21:21-5.
44. Adamu UG, Kolo PM, Katibi IA, et al. Relationship between left ventricular diastolic function and geometric patterns in Nigerians with newly diagnosed systemic hypertension. Cardiovasc J Afr 2009;20:173-7.
45. Karaye KM, Habib AG, Mohammed S, et al. Assessment of right ventricular systolic function using tricuspid annular-plane systolic excursion in Nigerians with systemic hypertension. Cardiovasc J Afr 2010;21:186-90.
46. Akintunde AA, Akinwusi PO, Opadijo GO. Relationship between Tei index of myocardial performance and left ventricular geometry in Nigerians with systemic hypertension. Cardiovasc J Afr 2010;22:124-7.
47. Adebiyi AA, Ogah OS, Aje A, et al. Echocardiographic partition values and prevalence of left ventricular hypertrophy in hypertensive Nigerians. BMC Med Imaging 2006;6:10.
48. Ogah OS, Akinyemi RO, Adegbite GD, et al. Prevalence of asymptomatic left ventricular systolic dysfunction in hypertensive Nigerians: echocardiographic study of 832 subjects. Cardiovasc J Afr 2011;22:297-302.
49. Akintunde AA, Akinwusi PO, Familoni OB, et al. Effect of systemic hypertension on right ventricular morphology and function: an echocardiographic study. Cardiovasc J Afr 2010;21:252-6.
50. Ogah OS, Bamgboye AE. Correlates of left ventricular mass in hypertensive Nigerians: an echocardiographic study. Cardiovasc J Afr 2010;21:79-85.
51. Odili AN, Richart T, Thijs L, et al. Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial. Blood Press 2011;20:256-66.
52. Odili AN, Richart T, Thijs L, et al. Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients. Trials 2012;13:59.
53. Charlton KE, Steyn K, Levitt NS, et al. Diet and blood pressure in South Africa: intake of foods containing sodium, potassium, calcium, and magnesium in three ethnic groups. Nutrition 2005;21:39-50. (Pubitemid 40127564)
54. Foodstuffs, Cosmetics and Disinfectants Act, 1972 (Act 54 of 1972). Pretoria: Department of Health, Republic of South Africa 2012:Regulations relating to the reduction of sodium in certain foodstuffs.
55. Bertram MY, Steyn K, Wentzel-Viljoen E, et al. The impact of reducing sodium content in high salt foods on cardiovascular disease in South Africa. S AfrMed J 2012;102:743-45.
56. Seedat YK, Rayner BL. South African hypertension guideline 2011. S Afr Med J 2011;14:57-83.
57. Lemogoum D, Seedat YK, Mabadeje AF, et al. Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa. J Hypertens 2003;21:1993-2000. (Pubitemid 38296855)
58. Okpechi IG, Schoeman HS, Longo-Mbenza B, et al. Achieving blood pressure goals study in uncontrolled hypertensive patients treated with a fixed-dose combination of ramipril/hydrochlorothiazide: the ASTRAL study. Cardiovasc J Afr 2011;22:79-84.
59. Sever PS, Dahlöf B, Poulter NR, et al. Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens 2001;19:1139-47. (Pubitemid 32493649)
60. Moser M, Roccella EJ. The treatment of hypertension: a remarkable success story. J Clin Hypertens 2013;15:88-91.